A new study shows that lung stem cell secretions – specifically exosomes and secretomes – delivered via nebulizer, can help repair lung injuries due to multiple types of pulmonary fibrosis in mice and rats.
A team of researchers from Roswell Park Comprehensive Cancer Center and the CDC report new evidence that inhalation of vitamin E acetate is strongly linked to e-cigarette, or vaping, product use-associated lung injury (EVALI).
UAB experts provide tips for you to prepare yourself in the event of the spread of COVID-19.
Led by Tony Hu, the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine, researchers are now developing a rapid, reliable and highly specific test to allow rapid diagnosis of all forms of Tuberculosis (TB).
A study by the American Academy of Sleep Medicine found that while approximately 30 million American adults have obstructive sleep apnea only about 6 million, or 20%, have been properly diagnosed and treated.
The ATS Foundation Research Program and the American Lung Association have awarded Donald Sullivan, MD, of Oregon Health & Science University a $100,000 Foundation Partner grant. The ATS Foundation Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.
The American Thoracic Society will host the world’s leading scientists and clinicians in pulmonary, critical care, and sleep medicine at the ATS 2020 International Conference (ATS 2020).
Doctors who use drugs that target antibiotic-resistant bacteria as a first-line defense against pneumonia should probably reconsider this approach, according to a new study of more than 88,000 veterans hospitalized with the disease. The study found that pneumonia patients given these medications in the first few days after hospitalization fared no better than those receiving standard medical care for the condition.
Findings from CT scans provide new insight that could lead to quicker diagnosis
Researchers reporting in ACS’ Environmental Science & Technology have compared PFAS in the serum of female firefighters and female office workers, finding higher levels of three compounds in the firefighters.
As of Feb. 25, 2020, the World Health Organization reported 79,339 confirmed cases of novel coronavirus, also known as COVID-19. Thirty-four countries have reported cases, including 2,619 deaths.The WHO has not declared COVID-19 as a pandemic — a situation defined somewhat vaguely by the WHO as “the worldwide spread of a new disease.
Harvard University scientists will collaborate with Chinese colleagues to elucidate the basic biology of the novel coronavirus (COVID-19), and the resulting disease, toward new diagnostic tools, vaccine development and antiviral therapies. The collaboration is part of a $115 million research initiative funded by China Evergrande Group.
Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E. Today, the World Health Organization reports that TB is still the leading cause of death worldwide from a single infectious agent, responsible for some 1.5 million fatalities annually. Primary treatment for TB for the past 50 years has remained unchanged and still requires patients to take multiple drugs daily for at least six months. Successful treatment with these anti-TB drugs — taken orally or injected into the bloodstream — depends on the medications “finding their way” into pockets of TB bacteria buried deep within the lungs.
Traditional stoves that burn biomass materials and are not properly ventilated, which are widely used in developing nations where cooking is done indoors, have been shown to significantly increase indoor levels of harmful PM2.5 (miniscule atmospheric particulates) and carbon monoxide (CO) and to stimulate biological processes that cause lung inflammation and may lead to chronic obstructive pulmonary disease (COPD), according to new research published online in the Annals of the American Thoracic Society.
Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer (NSCLC).
في ورقة بحثية جديدة نُشِرت بتاريخ 4 فبراير في شبكة JAMA, وصف باحثون من Mayo Clinic فوائد علاج تنفسي منزلي غير باضع ― يشتمل على نوع يُشار إليه بضغط مجرى التنفس الموجب ثنائي المستوى أو BiPAP ― لكثير من المرضى المصابين بداء الانسداد الرئوي المزمن. وذكر الفريق عددًا من الفوائد منها انخفاض الوفيات وانخفاض حالات دخول المستشفيات، وتقليل خطورة التنبيب وتحسن حالات ضيق التنفس وانخفاض عدد زيارات أقسام الطوارئ.
. Em um novo artigo publicado em 4 de fevereiro pela revista JAMA, os pesquisadores da Mayo Clinic descrevem os benefícios da terapia de ventilação não invasiva em casa, que exerce uma pressão positiva nas vias aéreas em dois níveis, ou BiPAP, para vários pacientes com doença pulmonar obstrutiva crônica (DPOC).
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right